Published in Hepatitis Weekly, September 4th, 2006
"The etiologic and prognostic factors for non-B, non-C HCC, which is defined by its seronegativity for both hepatitis B surface antigen and HCV antibody, remain unclear. Nonneoplastic liver tissue from 46 patients with non-B, non-C HCC were examined for hepatitis B virus (HBV) DNA and HCV RNA using in situ hybridization. Recurrence-free survival rates were compared between patients showing high or low HBV DNA expression," wrote T. Nakai and colleagues, Kinki University.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.